R. Löser

876 total citations
30 papers, 704 citations indexed

About

R. Löser is a scholar working on Molecular Biology, Surgery and Genetics. According to data from OpenAlex, R. Löser has authored 30 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Surgery and 6 papers in Genetics. Recurrent topics in R. Löser's work include Cholesterol and Lipid Metabolism (8 papers), Estrogen and related hormone effects (6 papers) and Lipoproteins and Cardiovascular Health (4 papers). R. Löser is often cited by papers focused on Cholesterol and Lipid Metabolism (8 papers), Estrogen and related hormone effects (6 papers) and Lipoproteins and Cardiovascular Health (4 papers). R. Löser collaborates with scholars based in Germany, Switzerland and United States. R. Löser's co-authors include Benno Rattel, Max Hasmann, Katja Wosikowski, Urs Eppenberger, N Breiter, Joachim Drevs, N. Esser, Karin Mattern, A. Sendl and Hildebert Wagner and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Lipid Research and International Journal of Cancer.

In The Last Decade

R. Löser

29 papers receiving 668 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
R. Löser 244 188 136 88 88 30 704
Yi‐Ru Chen 321 1.3× 178 0.9× 35 0.3× 158 1.8× 84 1.0× 65 1.2k
Shakti Ranjan Satapathy 606 2.5× 285 1.5× 54 0.4× 44 0.5× 117 1.3× 45 1.2k
Naomi Haga 531 2.2× 158 0.8× 94 0.7× 28 0.3× 60 0.7× 9 801
Annie Joubert 512 2.1× 182 1.0× 132 1.0× 39 0.4× 92 1.0× 44 1.1k
Qian Zhong 420 1.7× 209 1.1× 144 1.1× 77 0.9× 41 0.5× 41 862
Saswati Banerjee 257 1.1× 165 0.9× 30 0.2× 20 0.2× 58 0.7× 31 725
Mei Zhang 649 2.7× 275 1.5× 86 0.6× 63 0.7× 68 0.8× 56 1.2k
Keli Tian 594 2.4× 122 0.6× 41 0.3× 42 0.5× 43 0.5× 30 964
Hareesh B. Nair 259 1.1× 224 1.2× 191 1.4× 22 0.3× 25 0.3× 48 800
Vanessa Moreno 360 1.5× 120 0.6× 28 0.2× 34 0.4× 75 0.9× 10 668

Countries citing papers authored by R. Löser

Since Specialization
Citations

This map shows the geographic impact of R. Löser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Löser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Löser more than expected).

Fields of papers citing papers by R. Löser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Löser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Löser. The network helps show where R. Löser may publish in the future.

Co-authorship network of co-authors of R. Löser

This figure shows the co-authorship network connecting the top 25 collaborators of R. Löser. A scholar is included among the top collaborators of R. Löser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Löser. R. Löser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abletshauser, C., et al.. (2007). Time-of-intake (morning versus evening) of extended-release fluvastatin in hyperlipemic patients is without influence on the pharmacodynamics (mevalonic acid excretion) and pharmacokinetics. International Journal of Clinical Pharmacology and Therapeutics. 45(6). 328–334. 8 indexed citations
2.
Drevs, Joachim, R. Löser, Benno Rattel, & N. Esser. (2004). Antiangiogenic potency of FK866/K22.175, a new inhibitor of intracellular NAD biosynthesis, in murine renal cell carcinoma.. PubMed. 23(6C). 4853–8. 58 indexed citations
3.
Wosikowski, Katja, et al.. (2002). WK175, a novel antitumor agent, decreases the intracellular nicotinamide adenine dinucleotide concentration and induces the apoptotic cascade in human leukemia cells.. PubMed. 62(4). 1057–62. 79 indexed citations
5.
Scharnagl, Hubert, R. Löser, Markus Nauck, et al.. (2000). The effects of lifibrol (K12.148) on the cholesterol metabolism of cultured cells: evidence for sterol independent stimulation of the LDL receptor pathway. Atherosclerosis. 153(1). 69–80. 6 indexed citations
6.
Lang, Gerhard, et al.. (1998). Effects of pravastatin on cholesterol metabolism of cholesterol‐fed heterozygous WHHL rabbits. British Journal of Pharmacology. 124(2). 277–282. 4 indexed citations
8.
Hasmann, Max, Benno Rattel, & R. Löser. (1994). Preclinical data for Droloxifene. Cancer Letters. 84(2). 101–116. 48 indexed citations
9.
Wosikowski, Katja, Willy Küng, Max Hasmann, R. Löser, & Urs Eppenberger. (1993). Inhibition of growth‐factor‐activated proliferation by anti‐estrogens and effects on early gene expression of mcf‐7 cells. International Journal of Cancer. 53(2). 290–297. 40 indexed citations
10.
Sendl, A., et al.. (1992). Inhibition of cholesterol synthesis in vitro by extracts and isolated compounds prepared from garlic and wild garlic. Atherosclerosis. 94(1). 79–85. 67 indexed citations
11.
Steele‐Mortimer, Olivia, H. Meier-Ewert, R. Löser, & Max Hasmann. (1990). Flow cytometric analysis of vims-infected cells and its potential use for screening antiviral agents. Journal of Virological Methods. 27(3). 241–252. 17 indexed citations
12.
Kirchgeßner, M., et al.. (1990). Effects of the hypocholesterolemic compound K12.148 on serum lipids and parameters of clinical chemistry of pigs. Journal of Animal Physiology and Animal Nutrition. 63(1-5). 114–119. 6 indexed citations
13.
Löser, R., et al.. (1989). Hypolipemic activity of K12.148 in rats, marmosets and pigs.. PubMed. 16(2). 90–104. 14 indexed citations
14.
Löser, R., et al.. (1987). Circadian variation of the hypocholesterolemic effect of K13.004 in rats. Atherosclerosis. 64(2-3). 163–166. 4 indexed citations
15.
Löser, R., et al.. (1985). In vivo and in vitro antiestrogenic action of 3-hydroxytamoxifen, tamoxifen and 4-hydroxytamoxifen. European Journal of Cancer and Clinical Oncology. 21(8). 985–990. 46 indexed citations
16.
Eppenberger, Urs, W. Küng, R. Löser, & Werner Roos. (1984). In Vitro Characterization of New Antiestrogens in Human Mammary Tumor Cells. Recent results in cancer research. 94. 245–252. 2 indexed citations
17.
Howard, A.N., et al.. (1979). The hypocholesterolemic effect of terbufibrol and other drugs in normal and hypercholesterolemic baboons. Atherosclerosis. 32(4). 367–380. 4 indexed citations
18.
Lochner, W., et al.. (1978). The pressure-resistance relationships of regional resistances within the coronary circulation and the steal phenomenon. Basic Research in Cardiology. 73(6). 607–617. 5 indexed citations
19.
Zeiller, K., R. Löser, G. Pascher, & K. Hannig. (1975). Free-Flow Electrophoresis II. Analysis of the Method with Respect to Preparative Gell Separation. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 356(2). 1225–1244. 49 indexed citations
20.
Löser, R., P Boquet, & R. Röschenthaler. (1971). Inhibition of R-factor transfer by levallorphan. Biochemical and Biophysical Research Communications. 45(1). 204–211. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026